Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy

Table 2

Visual acuity measured before IV injection, three and six months after. Description of the number of letters won per patient (patient #1 to #10).

Patients	Visual acuity baseline	Letters	Visual acuity 3 months	Letters	Visual acuity 6 months
#1	20/160-2	4	20/160+2	2	20/160
#2	20/400	14	20/200-1	7	20/320+2
#3	20/400	7	20/320+2	0	20/400
#4	20/125-2	1	20/125-1	1	20/125-1
#5	20/125-2	4	20/125+2	7	20/100
#6	20/160-1	3	20/160+2	6	20/125
#7	20/640+2	22	20/200-1	7	20/400
#8	20/160-2	4	20/160+2	4	20/160+2
#9	20/125-1	4	20/100-2	4	20/100-2
#10	20/400-1	6	20/320	6	20/320